Original articlesPrimary hyperparathyroidism detected in a health screening: The Tromsø Study
Introduction
Primary hyperparathyroidism is diagnosed by demonstrating an inappropriately increased level of parathyroid hormone (PTH) in relation to that of serum calcium [1]. However, in larger population-based health surveys which included screening for primary hyperparathyroidism, the diagnosis has mainly been based on serum calcium measurements alone, since reliable assays for PTH were not available. Thus, for example, in a health screening from 1969 in Gävle, Sweden, which included more than 16,000 subjects, the prevalence of hypercalcaemia in the total population was found to be 0.7%, increasing to over 3% in women above the age of 60 [2]. Similarly, in a study from Stockholm in 1973 where some 21,000 subjects were screened, the prevalence was found to be 0.3% of the total population, increasing to 1.3% in older women [3]. This pattern has been confirmed in several hospital-based studies; there is now general agreement that the incidence of primary hyperparathyroidism is higher in women than men, and that it increases with age 4, 5.
In Tromsø, Norway, a large health survey was performed on more than 27,000 inhabitants during 1994–1995. Serum calcium was measured in all subjects, and those with levels above 2.59 mmol/L were re-examined. PTH was also measured in a subgroup of 990 subjects, thus affording an opportunity of determining the prevalence of primary hyperparathyroidism by a variety of criteria for its definition.
Section snippets
Subjects and definitions
The Tromsø study is a broad health survey first instituted in Norway in 1974. It is carried out by the National Health Screening Service in co-operation with the University of Tromsø and local health authorities. The present study is based on the fourth survey (1994–1995). A total of 12,866 men and 14,293 women participated, representing 74.2% and 79.0% of the eligible population, respectively. All subjects had blood samples drawn for serum calcium measurements. If serum calcium was ⩾2.60
Main study group: serum calcium measured during screening
Because only individuals below the age of 76 were included in the follow-up study, those above that age do not appear in the presentation below. The total number of subjects, therefore, comprised 12,339 men and 13,394 women.
Discussion
The present study indicates the increased prevalence of primary hyperparathyroidism in women, particularly those above the age of 70. Depending on the screening method and definition of primary hyperparathyroidism employed, the prevalence in this group ranged from 1.75% to 13.9%, underscoring the role consensus plays in the identification of this disease.
In attempting to diagnose primary hyperparathyroidism, it will be recalled that about 50% of total serum calcium exists in a free or ionized
Acknowledgements
The present study was supported by a grant from the Norwegian Research Council.
References (17)
- et al.
Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women
Surgery
(1997) - Consensus Development Conference Statement. J Bone Miner Res 1991;6(Suppl...
- et al.
Prevalence of hypercalcaemia in a health surveya 14 year follow-up study of serum calcium values
Eur J Clin Invest
(1988) - et al.
Prevalence of hypercalcaemia in a health screening in Stockholm
Acta Med Scand
(1976) - et al.
Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community
N Engl J Med
(1980) - et al.
The incidence and causes of hypercalcaemia
Postgrad Med J
(1987) - et al.
Association between heart rate and atherogenic blood lipid fractions in a population. The Tromsø study
Circulation
(1992) - et al.
Serum ionized calcium and the prevalence of primary hyperparathyroidism in age cohorts of 75, 80 and 85 years
J Intern Med
(1992)
Cited by (75)
Epidemiology of parathyroid disorders
2018, Best Practice and Research: Clinical Endocrinology and MetabolismThyroid and Parathyroid Diseases in Pregnancy
2016, Obstetrics: Normal and Problem PregnanciesMinimally Invasive Parathyroidectomy Versus Bilateral Neck Exploration for Primary Hyperparathyroidism
2016, Surgical Oncology Clinics of North AmericaCitation Excerpt :This results from overproduction of PTH by 1 or more of the parathyroid glands. The incidence of 10HPT is increasing overall as the population in the United States has aged, with incidence rates ranging from 0.7% in the general population up to 3% in postmenopausal women.1,10,11 10HPT occurs at a higher rate in women, at a 2:1 ratio,12 and is the most common cause of hypercalcemia in the outpatient population.
Epidemiology, pathogenesis of primary hyperparathyroidism: Current data
2015, Annales d'EndocrinologieCitation Excerpt :Variable prevalence data were obtained, depending on the diagnostic criteria: it was estimated, according to a Norway survey, that the prevalence of PHPT in Europe around 1990 ranged from 3.6 to 13.9% [1]. A population-based study on the incidence in Olmsted County, MN, USA, revealed that the annual incidence of PHPT in 1974 was 7.8/100,000/yr [2]. However, a year later in 1975, after the introduction of routine serum calcium measurement with automated chemistry panels, the incidence in the same population, adjusted for previously prevalent cases, rose to 27.7/100,000.
Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010)
2015, BoneCitation Excerpt :After the initial rise in PHPT diagnoses, the incidence fell to 27.7 per 100,000 person-years, which was thought to represent the true rate in an environment of automated measurement of serum calcium [3]. PHPT clinical characteristics also changed in the era of routine calcium measurement, from symptomatic disease with more severe hypercalcemia to asymptomatic PHPT with mild hypercalcemia that was more common in older women who are also at risk for osteoporosis [1–7]. Throughout the 1980s, the incidence of PHPT in Rochester steadily decreased, and this lower rate persisted throughout most of the 1990s [7,8].
Surgical Management of Hyperparathyroidism
2015, Endocrinology: Adult and Pediatric